Shanghai, China
PharmaResources is a leading small molecule CRO/CDMO service provider that has been at the forefront of drug development and commercialization since 2007. The company specializes in offering a comprehensive range of services, including drug discovery, pharmaceutical process research, and API/intermediate production, catering to the needs of global pharmaceutical companies.
With a firm commitment to "scientific driven, continuous innovation," PharmaResources aims to meet the evolving demands of its customers and the market, ensuring sustainable development in the dynamic pharmaceutical landscape. The company's offerings encompass new drug preclinical research services, synthesis process innovations, compound design, screening, optimization, structural modifications, and safety screening.
As a prominent player in the Manufacturing and Pharmaceutical industries, PharmaResources has carved a niche for itself as a reliable partner for companies seeking expertise in small molecule drug development. While specific details regarding the company's headquarters and recent investments are currently unavailable, its track record and commitment to excellence position it as an attractive prospect for potential investors seeking opportunities in the pharmaceutical sector.
